Argos Therapeutics' Debt - III Round

Argos Therapeutics raised a round of funding on July 22, 2011.

Argos Therapeutics, formerly Merix Bioscience, s a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infe…

Articles about Argos Therapeutics' Debt - III Round: